Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

被引：2
|
作者：
Levy, Benjamin Philip
Paz-Ares, Luis G.
Bennouna, Jaafar
Felip, Enriqueta
Abreu, Delvys Rodriguez
Isla, Dolores
Barlesi, Fabrice
Molinier, Olivier
Madelaine, Jeannick
Audigier-Valette, Clarisse
Kim, Sang-We
Ozguroglu, Mustafa
Erman, Mustafa
Badin, Firas Benyamine
Mekhail, Tarek
Scheff, Ronald J.
Riess, Jonathan W.
机构：
[1] Johns Hopkins Univ, Sch Med, Sibley Mem Hosp, Sidney Kimmel Comprehens Canc Ctr, Washington, DC USA
[2] Hosp Univ 12 Octubre, Madrid, Spain
[3] CNIO, Madrid, Spain
[4] Hop G & L Laennec, Nantes, France
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[7] Hosp Clin Lozano Blesa, Zaragoza, Spain
[8] Hosp Nord Serv Oncol, Marseille, France
[9] Ctr Hosp Le Mans, Le Mans, France
[10] Hopital Cote Nacre, Caen, France
[11] Hop St Musse, Toulon, France
[12] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[13] Istanbul Univ, Istanbul, Turkey
[14] Hacettepe Univ, Inst Canc, Ankara, Turkey
[15] Baptist Hlth Lexington Canc Ctr, Lexington, KY USA
[16] Florida Hosp Canc Inst, Orlando, FL USA
[17] Weill Cornell Med Coll, New York, NY USA
[18] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS9117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9117
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study
    Ekman, S.
    Planck, M.
    Sorensen, J. B.
    Horvat, P.
    Layton, D.
    Kim, J.
    Rosenlund, M.
    Juarez-Garcia, A.
    Daumont, M.
    Jacobs, H. C.
    Lacoin, L.
    Brustugun, O. T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] A phase II study of weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC).
    Yun, Fan
    Zhou, Xinming
    Jiang, Youhua
    Chen, Qixun
    Huang, Zhiyu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [43] Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
    Levy, Benjamin
    Barlesi, Fabrice
    Paz-Ares, Luis
    Bennouna, Jaafar
    Erman, Mustafa
    Felip, Enriqueta
    Isla, Dolores
    Kim, Hye Ryun
    Kim, Sang-We
    Madelaine, Jeannick
    Molinier, Olivier
    Ozguroglu, Mustafa
    Rodriguez Abreu, Delvys
    Adeniji, Abidemi
    Lorence, Robert M.
    Voccia, Isabelle
    Chisamore, Michael J.
    Riess, Jonathan W.
    LUNG CANCER, 2022, 166 : 107 - 113
  • [44] A novel combination therapy for lung squamous cell carcinoma
    Alqasrawi, Dania
    Argo, Ryan
    Rang, Christine Ratliff
    Pandya, Prita
    Klinge, Skyeler
    Lindemann, Jennifer
    Searl, Nyla
    Fields, Alan
    Justilien, Verline
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study
    Jelic, S
    Mitrovic, L
    Radosavljevic, D
    Elezar, E
    Babovic, N
    Kovcin, V
    Tomasevic, Z
    Kovacevic, S
    Gavrilovic, D
    Radulovic, S
    LUNG CANCER, 2001, 34 (01) : 1 - 13
  • [46] COMBINATION CHEMOTHERAPY IN SQUAMOUS-CELL CARCINOMA OF THE LUNG
    KRZAKOWSKI, MJ
    SWIERZ, J
    CHEMIOTERAPIA, 1984, 3 (02): : 75 - 78
  • [47] COMBINATION CHEMOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF LUNG
    LOWE, WC
    MIETLOWSKI, W
    PHILLIPS, R
    CHEST, 1976, 70 (03) : 433 - 433
  • [48] VINORELBINE PLUS CISPLATINUM FOR THE TREATMENT OF STAGE-IIIB AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA
    GEBBIA, V
    CARUSO, M
    VALENZA, R
    TESTA, A
    CANNATA, G
    VERDERAME, F
    CIPOLLA, C
    CURTO, G
    OLIVERI, D
    CHIARENZA, M
    LATTERI, MA
    DIGESU, G
    GEBBIA, N
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1247 - 1249
  • [49] A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
    Saba, Nabil F.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Patel, Mihir
    Schmitt, Nicole Cherie
    Stokes, William A.
    Bates, James Edward
    Rudra, Soumon
    Abousaud, Marin Ibrahim
    Muzaffar, Jameel
    Kirtane, Kedar
    Teng, Yong
    Steuer, Conor Ernst
    Shin, Dong Moon
    Liu, Yuan
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] UTILITY OF SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC) IN PATIENTS WITH CERVICAL SQUAMOUS-CELL CARCINOMA (CSCC)
    SENEKJIAN, EK
    YOUNG, JM
    WEISER, P
    HERBST, AL
    MAZUREK, C
    GYNECOLOGIC ONCOLOGY, 1986, 23 (02) : 248 - 249
12345